SOB-101

N/A

Report date: 2025/02/28 10:17:05

Base Information

Drug NameSOB-101
Drug Alias NameSOB101SOB-101
ClassificationBiologics > Exosomes
Mechanisms of ActionHLA class I histocompatibility antigen, alpha chain G modulators
TargetsHLA class I histocompatibility antigen, alpha chain G
Therapy Area/IndicationsSolid tumoursLung NeoplasmsBrain Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShine-On BioMedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShine-On BioMedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsBrain Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A